D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
NET Power
NPWR
$136M
| $2.57M | ﹤0.01% |
252,899
| – | – |
|
|
SGEN
2577
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.57M | ﹤0.01% |
20,000
-10,000
| -33% | -$1.29M |
|
2578
CALL
Zebra Technologies
ZBRA
$17.6B
| $2.56M | ﹤0.01% |
10,000
-26,400
| -73% | -$6.82M |
|
|
ICPT
2579
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.56M | ﹤0.01% |
207,082
+177,740
| +606% | +$2.52M |
|
2580
CALL
Wolfspeed
WOLF
$1.41B
| $2.55M | ﹤0.01% |
37,000
+10,000
| +37% | +$886K |
|
2581
CALL
Stanley Black & Decker
SWK
$15.5B
| $2.55M | ﹤0.01% |
34,000
+4,700
| +16% | +$367K |
|
2582
Nektar Therapeutics
NKTR
$2.46B
| $2.55M | ﹤0.01% |
75,194
+29,933
| +66% | +$1.45M |
|
2583
Butterfly Network
BFLY
$2.35B
| $2.54M | ﹤0.01% |
1,034,306
+342,755
| +50% | +$1.23M |
|
2584
Extra Space Storage
EXR
$31.7B
| $2.54M | ﹤0.01% |
17,287
-144,717
| -89% | -$23.1M |
|
|
NVEI
2585
CALL
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $2.54M | ﹤0.01% |
100,000
-1,000
| -1% | -$28.3K |
|
2586
PUT
O'Reilly Automotive
ORLY
$74.9B
| $2.53M | ﹤0.01% |
+45,000
| New | +$2.42M |
|
|
BELFB
2587
Bel Fuse Inc Class B
BELFB
$4.28B
| $2.53M | ﹤0.01% |
76,911
+3,646
| +5% | +$119K |
|
|
SPTN
2588
DELISTED
SpartanNash
SPTN
| $2.53M | ﹤0.01% |
83,659
+60,129
| +256% | +$1.96M |
|
2589
Kinsale Capital Group
KNSL
$8.26B
| $2.53M | ﹤0.01% |
+9,665
| New | +$2.79M |
|
2590
PUT
Hilton Worldwide
HLT
$70.2B
| $2.53M | ﹤0.01% |
20,000
| – | – |
|
2591
PUT
Hudbay
HBM
$11B
| $2.52M | ﹤0.01% |
500,000
| – | – |
|
2592
CALL
Nutanix
NTNX
$16.6B
| $2.52M | ﹤0.01% |
+96,900
| New | +$2.65M |
|
2593
Home BancShares
HOMB
$6.3B
| $2.52M | ﹤0.01% |
110,746
-99,104
| -47% | -$2.4M |
|
2594
SiTime
SITM
$17.5B
| $2.52M | ﹤0.01% |
24,815
+11,513
| +87% | +$1.09M |
|
2595
PUT
Targa Resources
TRGP
$56.4B
| $2.52M | ﹤0.01% |
34,300
-146,400
| -81% | -$10.2M |
|
2596
PUT
Brinker International
EAT
$9.36B
| $2.52M | ﹤0.01% |
79,000
-158,100
| -67% | -$4.97M |
|
|
NKGN
2597
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $2.51M | ﹤0.01% |
252,656
| – | – |
|
|
RAPT
2598
DELISTED
RAPT Therapeutics
RAPT
| $2.51M | ﹤0.01% |
15,838
+3,403
| +27% | +$545K |
|
2599
Plexus
PLXS
$7.41B
| $2.51M | ﹤0.01% |
24,349
+17,927
| +279% | +$1.81M |
|
2600
Dine Brands
DIN
$442M
| $2.51M | ﹤0.01% |
38,785
+32,330
| +501% | +$2.25M |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.